サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1654227

メディカルライティングにおけるAI市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年

AI In Medical Writing Market Size, Share, & Trends Analysis Report By Type (Clinical Writing, Type Writing), By End-use (Medical Devices, Pharmaceutical), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
メディカルライティングにおけるAI市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年
出版日: 2025年01月15日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

メディカルライティングにおけるAI市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のメディカルライティングにおけるAI市場規模は、2025～2030年にかけて12.52％のCAGRを記録し、2030年までに17億6,002万米ドルに達すると予測されています。

市場拡大の主要要因は、医療産業で人工知能（AI）などの機械学習が受け入れられつつあることです。さらに、医療費削減に対する需要の高まりや、経費削減のための製薬会社による研究開発投資の増加も、市場成長を後押しする要因となっています。COVID-19パンデミックは市場に緩やかな影響を与えました。パンデミックは研究開発活動や臨床検査の休止を引き起こしました。

さらに、予算の制約から多くの製薬企業が投資を削減しました。パンデミックの初期段階では、医療ジャーナルへの投稿も減少し、市場成長にマイナスの影響を与えました。しかし、革新的な治療法の開発における企業、研究グループ、政府機関の共同努力の意義は、COVID-19パンデミックの際に実証されました。その結果、医療機器、バイオテクノロジー、ライフサイエンス企業は、メディカルライターへの投資を強化する意向を持っています。このように、COVID-19パンデミックの間、医療産業におけるAIの需要が増加しています。

メディカルライティングAI市場レポートハイライト

  • タイプライティングセグメントは、当局への規制文書提出の必要性から、2024年の売上高全体の32.89%を占め、市場を独占しています。このため、このセグメントではメディカルライティングにおけるAI需要が高まっている
  • 最終用途別では、医薬品セグメントが2024年の収益シェア33.33%で市場を独占しました。
  • この高いシェアは、新薬や治療法を開発するための研究開発活動への投資が活発で、この最終用途セグメントにおけるメディカルライティング用AIの需要を増大させたことに起因しています。
  • 2024年には、北米が30.12%の収益シェアで市場を独占しました。これは、継続的な技術の進歩、医療インフラの増加、薬剤の臨床検査とその承認件数の多さによるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 メディカルライティングにおけるAI市場の変数、動向、範囲

  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 市場機会
  • メディカルライティング市場分析ツールにおけるAI
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19の影響分析
    • ケーススタディ

第4章 メディカルライティング市場におけるAI：タイプ別、推定・動向分析

  • タイプ別市場シェア、2024年と2030年
  • セグメントダッシュボード
  • 製品タイプ別メディカルライティングにおける世界のAI市場展望
  • 臨床ライティング
  • 科学論文ライティング
  • タイプライティング
  • その他

第5章 メディカルライティング市場におけるAI：最終用途別、推定・動向分析

  • 最終用途市場シェア、2024年と2030年
  • セグメントダッシュボード
  • 最終用途別メディカルライティングにおける世界のAI市場展望
  • 医療機器
  • 医薬品
  • バイオテクノロジー
  • その他

第6章 メディカルライティング市場におけるAI：地域推定・動向分析、製品別、タイプ別、最終用途別

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 世界地域市場のスナップショット
  • 市場規模と予測動向分析、2018～2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • 主要企業の市場シェア/ポジション分析、2024年
  • 企業プロファイル
    • Parexel International（MA）Corporation
    • Trilogy Writing &Consulting GmbH
    • Freyr
    • Cactus Communications
    • GENINVO
    • IQVIA Inc.
    • ICON plc
    • Syneos Health
    • IBM
    • Teladoc Health, Inc.
    • SmarterDx
    • Abridge Al, Inc.
    • Suki AI, Inc.
    • Movano
    • Heidi
    • Corti
    • Tortus AI.
    • Nabla Technologies
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 4 North America AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 5 U.S. AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 8 Canada AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 9 Mexico AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 10 Mexico AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 12 Europe AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 13 UK AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 14 UK AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 15 Germany AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 16 Germany AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 17 France AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 18 France AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 19 Italy AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 20 Italy AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 21 Spain AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 22 Spain AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 23 Denmark AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 24 Denmark AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 25 Sweden AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 26 Sweden AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 27 Norway AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 28 Norway AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 31 Japan AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 32 Japan AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 33 China AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 34 China AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 35 India AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 36 India AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 37 Australia AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 38 Australia AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 39 South Korea AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 40 South Korea AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 41 Thailand AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 42 Thailand AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 44 Latin America AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 45 Brazil AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 46 Brazil AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 47 Argentina AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 48 Argentina AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 49 MEA AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 50 MEA AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 51 South Africa AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 52 South Africa AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 53 Saudi Arabia AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 54 Saudi Arabia AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 55 UAE AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 56 UAE AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 57 Kuwait AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 58 Kuwait AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 AI in Medical Writing market outlook
  • Fig. 9 AI in Medical Writing competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 AI in Medical Writing market driver impact
  • Fig. 15 AI in Medical Writing market restraint impact
  • Fig. 16 AI in Medical Writing market strategic initiatives analysis
  • Fig. 17 AI in Medical Writing market: Type analysis
  • Fig. 18 AI in Medical Writing market: Type outlook and key takeaways
  • Fig. 19 Clinical writing market estimates and forecast, 2018 - 2030
  • Fig. 20 Type writing market estimates and forecast, 2018 - 2030
  • Fig. 21 Scientific writing market estimates and forecast, 2018 - 2030
  • Fig. 22 Others market estimates and forecast, 2018 - 2030
  • Fig. 23 AI in Medical Writing market: End use movement analysis
  • Fig. 24 AI in Medical Writing market: End use outlook and key takeaways
  • Fig. 25 Medical device market estimates and forecast, 2018 - 2030
  • Fig. 26 Pharmaceutical market estimates and forecast, 2018 - 2030
  • Fig. 27 Biotechnology market estimates and forecast, 2018 - 2030
  • Fig. 28 Others market estimates and forecast, 2018 - 2030
  • Fig. 29 Global AI in Medical Writing market: Regional movement analysis
  • Fig. 30 Global AI in Medical Writing market: Regional outlook and key takeaways
  • Fig. 31 Global AI in Medical Writing market share and leading players
  • Fig. 32 North America market share and leading players
  • Fig. 33 Europe market share and leading players
  • Fig. 34 Asia Pacific market share and leading players
  • Fig. 35 Latin America market share and leading players
  • Fig. 36 Middle East & Africa market share and leading players
  • Fig. 37 North America: SWOT
  • Fig. 38 Europe SWOT
  • Fig. 39 Asia Pacific SWOT
  • Fig. 40 Latin America SWOT
  • Fig. 41 MEA SWOT
  • Fig. 42 North America market estimates and forecasts, 2018 - 2030
  • Fig. 43 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 44 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 45 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 46 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 47 UK market estimates and forecasts, 2018 - 2030
  • Fig. 48 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 49 France market estimates and forecasts, 2018 - 2030
  • Fig. 50 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 51 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 52 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 53 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 54 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 55 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 56 China market estimates and forecasts, 2018 - 2030
  • Fig. 57 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 58 India market estimates and forecasts, 2018 - 2030
  • Fig. 59 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 60 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 61 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 62 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 63 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 64 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 65 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 66 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 67 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 68 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 69 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 70 Market share of key market players- AI in Medical Writing market
  • Fig. 71 Key Company Categorization
  • Fig. 72 Company Market Share/Position Analysis, 2024
  • Fig. 73 Strategic Framework
目次
Product Code: GVR-4-68040-097-9

AI In Medical Writing Market Growth & Trends:

The global AI in medical writing market size is anticipated to reach USD 1,760.02 million by 2030, registering a CAGR of 12.52% from 2025 to 2030, according to a new report by Grand View Research, Inc. The primary factor driving the market expansion is the growing acceptance of machine learning, such as Artificial Intelligence(AI), in the healthcare industry. Moreover, the rising demand for reducing healthcare expenditures and increasing R&D investments by pharmaceutical companies to reduce expenses are other factors that are propelling market growth. The COVID-19 pandemic had affected the market moderately. The pandemic caused a pause in research and development activities as well as clinical trials.

Moreover, budgetary limitations led many pharmaceutical companies to reduce their investments. The initial stages of the pandemic also resulted in a decrease in submissions to healthcare journals, negatively impacting market growth. However, the significance of collaborative efforts between companies, research groups, and government bodies in the development of innovative therapies was demonstrated during the COVID-19 pandemic. Consequently, medical device, biotechnology, and life science companies have intentions to boost their investment in medical writers. Thus, increasing the demand for AI in the healthcare industry during the COVID-19 pandemic.

AI In Medical Writing Market Report Highlights:

  • Based on type, the typewriting segment dominated the market with a share of 32.89% of the overall revenue in 2024 due to the necessity of submitting regulatory documents to the authorities. Thus, boosting the demand for AI in medical writing in this segment
  • Based on end-use, the pharmaceutical segment dominated the market with a revenue share of 33.33% in 2024.
  • The high share was attributed to the heavy investments in R&D activities to develop new drugs and treatments, which augmented the demand for AI in medical writing in this end-use segment
  • In 2024, North America dominated the market with a revenue share of 30.12% owing to the continuous technological advancements, increasing healthcare infrastructure, and a high number of drug trials & their approvals

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. End Use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. AI in Medical Writing Market Variables, Trends & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market driver analysis
    • 3.1.2. Market restraint analysis
    • 3.1.3. Market Opportunities
  • 3.2. AI in Medical Writing Market Analysis Tools
    • 3.2.1. Industry Analysis - Porter's
      • 3.2.1.1. Supplier power
      • 3.2.1.2. Buyer power
      • 3.2.1.3. Substitution threat
      • 3.2.1.4. Threat of new entrant
      • 3.2.1.5. Competitive rivalry
    • 3.2.2. PESTEL Analysis
      • 3.2.2.1. Political landscape
      • 3.2.2.2. Economic landscape
      • 3.2.2.3. Social landscape
      • 3.2.2.4. Technological landscape
      • 3.2.2.5. Environmental landscape
      • 3.2.2.6. Legal landscape
    • 3.2.3. COVID-19 Impact Analysis
    • 3.2.4. Case Studies

Chapter 4. AI in Medical Writing Market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global AI in Medical Writing Market by Product Type Outlook
  • 4.4. Clinical Writing
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Scientific Writing
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6. Type Writing
    • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. AI in Medical Writing Market: End Use Estimates & Trend Analysis

  • 5.1. End Use Market Share, 2024 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global AI in Medical Writing Market by End Use Outlook
  • 5.4. Medical Devices
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Pharmaceutical
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Biotechnology
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. AI in Medical Writing Market: Regional Estimates & Trend Analysis, By Product, By Type, By End Use

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Key company market share/position analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Parexel International (MA) Corporation.
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Technology Type benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Trilogy Writing & Consulting GmbH
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Technology Type benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Freyr
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Technology Type benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Cactus Communications
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Technology Type benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. GENINVO
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Technology Type benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. IQVIA Inc.
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Technology Type benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. ICON plc
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Technology Type benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Syneos Health
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Technology Type benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. IBM
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Technology Type benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Teladoc Health, Inc.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Technology Type benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. SmarterDx
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Technology Type benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. Abridge Al, Inc.
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Technology Type benchmarking
      • 7.4.12.4. Strategic initiatives
    • 7.4.13. Suki AI, Inc.
      • 7.4.13.1. Company overview
      • 7.4.13.2. Financial performance
      • 7.4.13.3. Technology Type benchmarking
      • 7.4.13.4. Strategic initiatives
    • 7.4.14. Movano
      • 7.4.14.1. Company overview
      • 7.4.14.2. Financial performance
      • 7.4.14.3. Technology Type benchmarking
      • 7.4.14.4. Strategic initiatives
    • 7.4.15. Heidi
      • 7.4.15.1. Company overview
      • 7.4.15.2. Financial performance
      • 7.4.15.3. Technology Type benchmarking
      • 7.4.15.4. Strategic initiatives
    • 7.4.16. Corti
      • 7.4.16.1. Company overview
      • 7.4.16.2. Financial performance
      • 7.4.16.3. Technology Type benchmarking
      • 7.4.16.4. Strategic initiatives
    • 7.4.17. Tortus AI.
      • 7.4.17.1. Company overview
      • 7.4.17.2. Financial performance
      • 7.4.17.3. Technology Type benchmarking
      • 7.4.17.4. Strategic initiatives
    • 7.4.18. Nabla Technologies
      • 7.4.18.1. Company overview
      • 7.4.18.2. Financial performance
      • 7.4.18.3. Technology Type benchmarking
      • 7.4.18.4. Strategic initiatives